To study the outcome of inpatient rehabilitation in multiple sclerosis (MS), we con-ducted retrospective chart review and follow-up telephone interviews (six to thirty-six months after discharge) with thirty-seven consecutive MS patients admitted for reha-bilitation following functional decline related to disease activity, trauma, or surgery. Functional Independence Measure (FIM), Kurtzke Functional Systems (FS), and Expanded Disability Status Scale (EDSS) scores at admission, discharge, and follow-up were analyzed. Of the thirty-seven patients, six had relapsing-remitting (RR), five relapsing progressive (RP), and twenty-six chronic progressive (CP) disease patterns. For all groups combined, significant improvements between admission and d...
Introduction: Multiple sclerosis (MS) is a chronic, autoimmune and progressive multifocal demyelinat...
Several rehabilitation programmes aim at reducing the impact of fatigue in MS patients. Acute and ch...
Cognitive impairment (CI) occurs in about 40-65% of people with multiple sclerosis (MS) during the d...
Patients with relapsing-remitting multiple sclerosis (RR MS) often make incomplete recovery from dis...
The aim of this outcome study was to evaluate the effectiveness and prognostic factors of inpatient ...
Multiple sclerosis (MS) is one of the most common neurological diseases in the United States, with r...
: Multiple sclerosis (MS) is a chronic, debilitating disease characterised by demyelination of the n...
Despite the well-known benefits of using standardized outcome measures (OMs) in clinical practice, a...
BACKGROUND: The impact of post-acute rehabilitative services provided in skilled nursing facilities ...
As multiple sclerosis (MS) has a dynamic process, monitoring of the disability is important in the r...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous s...
Background: Persons with multiple sclerosis may benefit from hospital-based multidisciplinary rehabi...
Multiple sclerosis (MS) often leads to different levels of severity and progression of impairment an...
Background/purpose: Multiple Sclerosis (MS) is a central nervous disorder that has a prevalence of 3...
SIGLEAvailable from British Library Document Supply Centre-DSC:DXN022203 / BLDSC - British Library D...
Introduction: Multiple sclerosis (MS) is a chronic, autoimmune and progressive multifocal demyelinat...
Several rehabilitation programmes aim at reducing the impact of fatigue in MS patients. Acute and ch...
Cognitive impairment (CI) occurs in about 40-65% of people with multiple sclerosis (MS) during the d...
Patients with relapsing-remitting multiple sclerosis (RR MS) often make incomplete recovery from dis...
The aim of this outcome study was to evaluate the effectiveness and prognostic factors of inpatient ...
Multiple sclerosis (MS) is one of the most common neurological diseases in the United States, with r...
: Multiple sclerosis (MS) is a chronic, debilitating disease characterised by demyelination of the n...
Despite the well-known benefits of using standardized outcome measures (OMs) in clinical practice, a...
BACKGROUND: The impact of post-acute rehabilitative services provided in skilled nursing facilities ...
As multiple sclerosis (MS) has a dynamic process, monitoring of the disability is important in the r...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous s...
Background: Persons with multiple sclerosis may benefit from hospital-based multidisciplinary rehabi...
Multiple sclerosis (MS) often leads to different levels of severity and progression of impairment an...
Background/purpose: Multiple Sclerosis (MS) is a central nervous disorder that has a prevalence of 3...
SIGLEAvailable from British Library Document Supply Centre-DSC:DXN022203 / BLDSC - British Library D...
Introduction: Multiple sclerosis (MS) is a chronic, autoimmune and progressive multifocal demyelinat...
Several rehabilitation programmes aim at reducing the impact of fatigue in MS patients. Acute and ch...
Cognitive impairment (CI) occurs in about 40-65% of people with multiple sclerosis (MS) during the d...